Ryan Golhar

机构：Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (Sweden), Bristol-Myers Squibb (Belgium)

发表论文 25 篇 · 总被引 2295 次 · h-index 13

代表论文

• Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer (2018 · Cancer Cell · 被引 905)
• Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming (2014 · Proceedings of the National Academy of Sciences · 被引 307)
• Increased Frequency of De Novo Copy Number Variants in Congenital Heart Disease by Integrative Analysis of Single Nucleotide Polymorphism Array and Exome Sequence Data (2014 · Circulation Research · 被引 277)
• Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer (2019 · Cancer Cell · 被引 220)
• Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer (2018 · Frontiers in Immunology · 被引 129)
• Whole-genome DNA/RNA sequencing identifies truncating mutations in RBCK1 in a novel Mendelian disease with neuromuscular and cardiac involvement (2013 · Genome Medicine · 被引 96)